
The governors of Washington, California, and Oregon have launched the West Coast Health Alliance to provide evidence-based guidance amid shifting CDC policies.
The governors of Washington, California, and Oregon have launched the West Coast Health Alliance to provide evidence-based guidance amid shifting CDC policies.
Rising cases of accidental nicotine exposure in children prompt an FDA warning and safety call to manufacturers.
A large cohort study finds elevated risks of sepsis, genitourinary infections, and longer hospital stays in patients with hidradenitis suppurativa (HS).
Weekly mobile messages improved blood sugar, blood pressure, and heart health risk management in patients with type 2 diabetes (T2D), a study finds.
The anti-amyloid maintenance therapy offers a once-weekly, subcutaneous option after 18 months of intravenous treatment.
The Mediterranean diet and aerobic exercise significantly reduced weight, liver enzymes, and waist circumference in patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH), a study finds.
New research highlights which US counties lead in patient experience, health outcomes, and cost efficiency—and the policies that drive success.
A study of children with type 1 diabetes (T1D) reveals major disparities in access to insulin and modern technologies, with significant impacts on glycemic control.
Race, ethnicity, and social factors can influence survival outcomes in adults with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL) receiving brexucabtagene autoleucel (brexu-cel).
A review of 59 studies finds inconsistent knowledge, attitudes, and practices among health care professionals in detecting diabetic retinopathy.
Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and mortality in patients with type 2 diabetes (T2D), according to one study.
A new study finds that drugmakers’ use of overlapping patents delayed generic entry for 4 top-selling drugs, driving billions in excess spending.
New drugs aren't the only advances in oncology. Innovation includes collaboration between to remove barriers to remove barriers to care, according to experts who gathered for a session of the Institute for Value-Based Medicine in Arlington, Virginia.
A new TIAA Institute report says solving workforce shortages with smarter hiring, training, and artificial intelligence could ease the rising demand for care from an aging population.
A UK cohort study finds socioeconomic deprivation in early life is tied to greater eating disorder symptoms in adolescence, with barriers to care.
A novel image-based deep learning approach achieves high accuracy and interpretability, offering potential for clinical decision support.
National Psoriasis Awareness Month offers an opportunity to examine how advances in systemic therapy, combined with patient-centered care models, are reshaping the treatment landscape.
There is a low but increased risk of optic nerve disorders in patients with type 2 diabetes prescribed semaglutide or tirzepatide, according to a large cohort study.
Combining perioperative comfort care with targeted operating room nursing reduces stress, pain, and recovery times in patients with colorectal cancer, according to one study.
From pump choices to TikTok trends, building trust with young patients means meeting them and their families where they are.
With growing roles in inpatient care and new telehealth models, pediatric pharmacists are reshaping how and where children receive specialized medication support, explained Marry Vuong, PharmD, BCPPS, of Perfecting Peds.
Shared decision-making helps dermatologists align treatment plans with patient needs, improving adherence and outcomes.
A national survey finds patients want personal contact after positive cancer results, with psychosocial fears outweighing cost and transportation concerns.
Long-term exposure to pollutants was linked to higher psoriasis risk, especially in people with genetic predispositions.
A national study finds technology use and blood sugar control are up in youths and adults with type 1 diabetes, yet racial, ethnic, and socioeconomic gaps persist.
A 6-year follow-up study finds berberine reduces adenoma and neoplasm rates after polypectomy, highlighting its potential for long-term chemoprevention.
A multicenter study finds no difference in outcomes between frail and nonfrail elderly patients treated with tildrakizumab over 2 years.
Interclass biologic switching can improve outcomes, but it also increases infection rates.
Artificial intelligence–powered insulin dosing and virtual coaching offer faster answers and convenience, but accuracy and oversight are key to building trust.
A new partnership delivers a scalable Fast Healthcare Interoperability Resources solution to help payers meet CMS' Interoperability and Prior Authorization Final Rule by 2027.
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.